| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 15 |
| 1 | CAPECITABINE | 7 |
| 2 | FUROSEMIDE | 7 |
| 3 | CARBOPLATIN | 6 |
| 4 | CYCLOPHOSPHAMIDE | 6 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 7 | ASPIRIN | 5 |
| 8 | ASPIRIN 325 MG | 5 |
| 9 | ASPIRIN 81 MG | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 1 | 0.0012 |
| 1 | NISOLDIPINE | 1 | 0.0008 |
| 2 | BRIGATINIB | 3 | 0.0008 |
| 3 | PRALSETINIB | 1 | 0.0005 |
| 4 | BENAZEPRIL HYDROCHLORIDE | 2 | 0.0003 |
| 5 | ALECTINIB HYDROCHLORIDE | 2 | 0.0003 |
| 6 | LORLATINIB | 2 | 0.0003 |
| 7 | MEGESTROL ACETATE | 1 | 0.0003 |
| 8 | SACITUZUMAB GOVITECAN | 1 | 0.0002 |
| 9 | RADIUM RA 223 DICHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 21 | 0.0002 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 5 | 0.0000 |